Subcellular localization of YKL-40 in normal and malignant epithelial cells of the breast

Ultrastructural Pathology

Volumn 32, Issue 3, 2008, Pages 101-106

  Roslind, Anne ^a   Balslev, Eva ^a   Kruse, Hanne ^a   Stærgaard, Bente ^a   Horn, Thomas ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Breast tissue; CHI3L1; Immunoelectron microscopy; Immunogold labeling; Tumor cells; YKL 40

Indexed keywords

GLYCOPROTEIN; YKL 40 PROTEIN;

ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER CELL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DESMOSOME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOGOLD LABELING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DESMOSOMES; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, IMMUNOELECTRON; TUMOR MARKERS, BIOLOGICAL;

EID: 45849140567     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.1080/01913120801937673     Document Type: Article

References (35)

1. Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA. Serum YKL-40, a new prognostic biomarker in cancer patients? Cancer Epidemiol Biomarkers Prev. 2006;15:194-202.
2. Kim SH, Das K, Noreen S, Coffman F, Hameed M. Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer. World J Surg Oncol. (serial online). February 2007; issue 5.
3. Roslind A, Knoop AS, Jensen M, et al. Immunohistochemical expression of YKL-40 is not a prognostic marker in patients with high-risk primary breast cancer. Presented as poster # 1052 at the San Antonio International Breast Cancer Symposium, December 13-16, 2007.
4. Pelloski CE, Mahajan A, Maor M, et al. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Clin Cancer Res. 2005;11:3326-3334.
5. Volck B, Price PA, Johansen JS, et al. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians. 1998;110:351-360.
6. Renkema GH, Boot RG, Au FL, et al. Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem. 1998;251:504-509.
7. Rehli M, Krause SW, Andreesen R. Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics. 1997;43:221-225.
8. Johansen JS, Williamson MK, Rice JS, Price PA. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res. 1992;7:501-512.
9. Junker N, Johansen JS, Hansen LT, Lund EL, Kristjansen PE. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. Cancer Sci. 2005;96:183-190.
10. Morrison BW, Leder P. Neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene. 1994;9:3417-3426.
11. Johansen JS, Høyer PE, Larsen LA, Price PA, Møllgård K. YKL-40 protein expression in the early developing human musculoskeletal system. J Histochem Cytochem. (serial online).
12. Ringsholt M, Hogdall EV, Johansen JS, Price PA, Christensen LH. YKL-40 protein expression in normal adult human tissues - an immunohistochemical study. J Mol Histol. 2007;38:33-43.
13. Roslind A, Johansen JS, Junker N, et al. YKL-40 expression in benign and malignant lesions of the breast: a methodologic study. Appl Immunohistochem Mol Morphol. 2007;15:371-381.
14. Qin W, Zhu W, Schlatter L, et al. Increased expression of the inflammatory protein YKL-40 in precancers of the breast. Int J Cancer. 2007;121:1536-1542.
15. Nutt CL, Betensky RA, Brower MA, et al. YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas. Clin Cancer Res. 2005;11:2258-2264.
16. Lau SH, Sham JS, Xie D, et al. Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene. 2006;25:1242-1250.
17. Roslind A, Johansen JS, Christensen IJ, et al. High serum levels in patients with squamous cell carcinoma of the head and neck is associated with short survival. Int J Cancer (serial online). October 2007.
18. Johansen JS, Jensen BV, Roslind A, Price PA. Is YKL-40 a new therapeutic target in cancer? Expert Opin Ther Targets. 2007;11:219-234.
19. Johansen JS, Roslind A, Palle C, et al. Serum YKL-40 levels in patients with cervical cancer are elevated compared to patients with cervical intraepithelial neoplasia and healthy controls. ASCO Annual Meeting Proceedings 2006, Poster # 5047, Atlanta, Georgia, USA.
20. Junker N, Johansen JS, Andersen CB, Kristjansen PE. Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer. Lung Cancer. 2005;48:223-231.
21. Recklies AD, White C, Ling H. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J. 2002;365(Pt 1):119-126.
22. Pelloski CE, Lin E, Zhang L, et al. Prognostic associations of activated mitogen-activated protein kinase and akt pathways in glioblastoma. Clin Cancer Res. 2006;12:3935-3941.
23. Ling H, Recklies AD. The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha. Biochem J. 2004;380(Pt 3):651-659.
24. Malinda KM, Ponce L, Kleinman HK, Shackelton LM, Millis AJ. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res. 1999;250:168-173.
25. Nishikawa KC, Millis AJ. gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp Cell Res. 2003;287:79-87.
26. Mohanty AK, Singh G, Paramasivam M, et al. Crystal structure of a novel regulatory 40 kDa mammary gland protein (MGP-40) secreted during involution. J Biol Chem. 2003;278:14451-14460.
27. Bigg HF, Wait R, Rowan AD, Cawston TE. The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation. J Biol Chem. 2006;281:21082-21095.
28. WHO Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Oxford, UK: Lyon International Agency for Research on Cancer and Oxford University Press; 2003.
29. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-410.
30. Kim S, Coulombe PA. Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm. Genes Dev. 2007;21:1581-1597.
31. Green KJ, Jones JC. Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB J. 1996;10:871-881.
32. Johansen JS, Olee T, Price PA, et al. Regulation of YKL-40 production by human articular chondrocytes. Arthritis Rheum. 2001;44:826-837.
33. Kzhyshkowska J, Gratchev A, Goerdt S. Human chitinases and chitinase-like proteins as indicators for inflammation and cancer. Biomarker Insights. 2007;2:128-146.
34. Renkema GH, Boot RG, Strijland A, et al. Synthesis, sorting, and processing into distinct isoforms of human macrophage chitotriosidase. Eur J Biochem. 1997;244:279-285.
35. Kzhyshkowska J, Mamidi S, Gratchev A, et al. Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood. 2006;107:3221-3228.